Related Experiment Video
Updated: Jun 23, 2026
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
The Importance of Continued Vigilance after Risk-Reducing Mastectomy in BRCA Carriers: A Case Report
Chiara Della Pepa1,2, Gemma Caliendo3, Alessia Mignano1
1Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Introduction:
Risk-reducing mastectomy (RRM) is safe and effective in preventing breast cancer (BC) in BRCA mutation carriers. Nipple-sparing mastectomy (NSM) has become the new standard due to better esthetic result and comparable efficacy profile. After RRM, the risk of developing BC still exists though hardly quantifiable due to few data in literature.
Case Presentation:
We describe the case of a 70-year-old woman who was found to harbor a BRCA2 mutation after diagnosis of ovarian cancer (OC) in her sister, underwent prophylactic surgery for BC and OC, as per international guidelines, and 4 years after was diagnosed with BC, metastatic to the ipsilateral axillary lymph nodes.
Conclusion:
This case highlights the importance of going on with active surveillance after RRM and the need of developing dedicated protocols about follow-up and breast imaging for these patients.
More Related Videos
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
